Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3791

Biogen taps City Therapeutics in RNAi deal worth up to $1B

$
0
0
Biogen is diving into the RNAi field with City Therapeutics, a biotech led by several former Alnylam leaders. City will apply its RNAi engineering chops and Biogen will supply drug delivery technology to first create ...

Viewing all articles
Browse latest Browse all 3791

Trending Articles